Preliminary safety data from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or oesophagogastric ...
—Before making a decision about splenectomy, get a thorough hematopathology review of available diagnostic material—and advice from a lymphoma specialist. Reviewed by Chaitra Ujjani, MD, Associate ...
The 4- and 11-year survival rates were 94 (61/65) and 60 % (39/65), respectively. Four patients died. Two patients survived for 152 and 278 days. The cause of death was complete occlusion of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results